12/12/2025
California Institute of Regenerative Medicine has approved a grant to Savanna Biotherapeutics for $12,993,456 to continue their work in ALSP. This investment dedicated to preclinical development for CSF1R leukoencephalopathy (ALSP) is a significant milestone in their work towards a CURE.
https://www.cirm.ca.gov/about-cirm/newsroom/press-releases/cirm-approves-over-160m-to-support-preclinical-and-clinical-research-advances-education-opportunities-and-access-to-clinical-trials/
Access to clinical trials shouldn’t depend on where you live.
That’s why CIRM has approved $27 million to establish three Community Care Centers of Excellence (CCCEs) across California—in South Los Angeles, the Inland Empire and Desert Region, and in the Central Valley.
These centers will expand access to cutting-edge stem cell and gene therapy clinical trials for conditions such as cancer, Parkinson’s, and sickle cell disease, while also training the next generation of regenerative medicine professionals.
Together, the CCCEs mark a major step toward ensuring Californians have access to life-changing treatments close to home.
Read the full press release here: https://bit.ly/3Wwl4Rq